NOD2 and obesity due to melanocortin 4 receptor deficiency: In vivo studies have reported that NOD2 stimulation by MDP improves insulin sensitivity, enhances glucose tolerance, and prevents obesity (Cavallari et al. 2017; Denou et al. 2015; Williams et al. 2020).